-
aTyr Pharma Announces Commencement of Public Offering of Common Stock
-
aTyr Pharma to Present at Upcoming Investor Conferences in May
-
UPDATE: RBC Capital Starts aTyr Pharma (LIFE) at Outperform
-
aTyr Pharma Announces Closing of $86.3 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
aTyr Pharma (LIFE) Prices $75 Million Public Offering of Common Stock at $8/share
-
aTyr Pharma Announces Pricing of $75 Million Public Offering of Common Stock
-
aTyr Pharma (LIFE) Shares Fall Following Common Stock Offering News
-
aTyr Pharma (LIFE) to Offer Common Stock
-
aTyr Pharma Announces Proposed Public Offering of Common Stock
-
Pre-Open Stock Movers 03/31: (GNCA) (MDVN) (MNOV) Higher; (EGLE) (PRGS) (MOV) Lower (more...)
-
After-Hours Stock Movers 03/30: (MDVN) (ANY) (MU) Higher; (PRGS) (SLW) (SUNE) Lower (more...)
-
Notable Analyst Rating Changes 6/1: (C) (KO) (ABEV) Upgraded; (CLD) (JNPR) (MRTX) Downgraded
-
Notable Analyst Rating Changes 12/20: (KLAC) (LIFE) (CAM) Upgraded; (T) (OC) (NVLS) Downgraded
-
Notable Analyst Rating Changes 08/16: (S) (PPL) (ARO) Upgraded; (MMI) (RIMM) (DIS) Downgraded
-
RBC Capital Upgrades Life Technologies (LIFE) to Outperform
-
Notable Analyst Rating Changes 04/27: (FSLR) (CRME) (IACI) Upgraded; (WDC) (SWY) (SIRI) Downgraded
-
RBC Capital Downgrades Life Technologies (LIFE) to Sector Perform
-
RBC Capital Initiates Coverage on Life Technologies (LIFE) with an Outperform
-
Morning Movers 4/29: DNDN, DWA, MSPD, PFWD, PSYS Higher; ETFC, BCRX, ROC, BLDP, SSYS Lower